MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer ; volume:19 ; number:1 ; day:4 ; month:3 ; year:2020 ; pages:1-15 ; date:12.2020
Molecular cancer ; 19, Heft 1 (4.3.2020), 1-15, 12.2020
- Urheber
-
Xu, Juan
Shao, Tingting
Song, Mingxu
Xie, Yunjin
Zhou, Jialiang
Yin, Jiaqi
Ding, Na
Zou, Haozhe
Li, Yongsheng
Zhang, Jiwei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-020-01174-w
- URN
-
urn:nbn:de:101:1-2020052321564427193682
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xu, Juan
- Shao, Tingting
- Song, Mingxu
- Xie, Yunjin
- Zhou, Jialiang
- Yin, Jiaqi
- Ding, Na
- Zou, Haozhe
- Li, Yongsheng
- Zhang, Jiwei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer
ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling
AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-β signaling pathway in cholangiocarcinoma
G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
GPR56 facilitates hepatocellular carcinoma metastasis by promoting the TGF-β signaling pathway
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy
MicroRNA-93 acts as an “anti-inflammatory tumor suppressor” in glioblastoma
Correction to: Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy
Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer
ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling
AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-β signaling pathway in cholangiocarcinoma
G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
GPR56 facilitates hepatocellular carcinoma metastasis by promoting the TGF-β signaling pathway
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy
MicroRNA-93 acts as an “anti-inflammatory tumor suppressor” in glioblastoma
Correction to: Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy
Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer
ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling
AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-β signaling pathway in cholangiocarcinoma
G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
GPR56 facilitates hepatocellular carcinoma metastasis by promoting the TGF-β signaling pathway
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy
MicroRNA-93 acts as an “anti-inflammatory tumor suppressor” in glioblastoma
Correction to: Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy